Jaguar Health (NASDAQ:JAGX) Shares Cross Below Two Hundred Day Moving Average – What’s Next?

Jaguar Health, Inc. (NASDAQ:JAGX)’s stock price passed below its two hundred day moving average during trading on Friday . The stock has a two hundred day moving average of $22.45 and traded as low as $4.29. Jaguar Health shares last traded at $4.37, with a volume of 29,507 shares trading hands.

Analysts Set New Price Targets

Separately, StockNews.com assumed coverage on shares of Jaguar Health in a report on Friday, March 28th. They set a “sell” rating for the company.

Jaguar Health Stock Performance

The company has a debt-to-equity ratio of 1.65, a quick ratio of 1.36 and a current ratio of 1.84. The business has a 50 day simple moving average of $14.87 and a 200 day simple moving average of $22.45.

Hedge Funds Weigh In On Jaguar Health

An institutional investor recently bought a new position in Jaguar Health stock. Virtu Financial LLC acquired a new position in shares of Jaguar Health, Inc. (NASDAQ:JAGX) in the 3rd quarter, according to its most recent disclosure with the SEC. The institutional investor acquired 25,591 shares of the biotechnology company’s stock, valued at approximately $35,000. Virtu Financial LLC owned approximately 0.22% of Jaguar Health as of its most recent filing with the SEC. 12.04% of the stock is currently owned by hedge funds and other institutional investors.

Jaguar Health Company Profile

Jaguar Health, Inc, a commercial stage pharmaceuticals company, focuses on developing plant-based prescription medicines for people and animals with gastrointestinal distress, specifically chronic and debilitating diarrhea. The company operates through two segments, Human Health and Animal Health. It focuses on developing and commercializing prescription and non-prescription products for companion and production animals; and human products.